Tag: Zydus Lifesciences
Sentynl Therapeutics announces FDA approval of ZYCUBO
Now the first and only therapy approved for the treatment of Menkes disease in the United States
Dr Sharvil Patel named IPA President; Glenn Saldanha takes over as...
Dr Sharvil Patel, Managing Director, Zydus Lifesciences appointed as President, IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark, appointed as Vice President, IPA
In a first, Zydus Lifesciences to launch vaccine against new strain...
Quadrivalent Inactivated Influenza vaccine - VaxiFlu - 4 to offer seasonal protection against 4 new virus strains
Padma Bhushan bestowed on Pankaj Patel: Zydus Chairman calls himself fortunate,...
Under his leadership, Zydus continues to innovate, aiming to provide affordable healthcare solutions worldwide
WHO prequalifies Zydus’s Typhoid Vi Conjugate Vaccine, ZyVac® TCV
Company receives acceptability, in principle, for ZyVac® TCV making it eligible for purchase by United Nations procurement agencies
CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...
Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets
Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in ALS...
Usnoflast, a novel oral NLRP3 inflammasome inhibitor, shows promising results in reducing neurodegeneration and improving key health markers
Zydus to acquire 50% stake in Sterling Biotech to enter into...
Post this transaction, Sterling Biotech will become a 50:50 Joint Venture with equal representation on the Board
Zydus Lifesciences secures COFEPRIS approval to market MamitraTM in Mexico for...
With the approval of MamitraTM, Zydus aims to provide affordable cancer treatments for HER2-positive breast and gastric cancer patients
Zydus and Takeda partner to market Vonoprazan in India
Innovative drug to offer new treatment options for GERD and acid peptic disorders, enhancing healthcare in India